Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

OBJECTIVES: The aim of this study was to develop a discrete-time simulation model for people with type 1 diabetes mellitus, to estimate and compare mean life expectancy and quality-adjusted life-years (QALYs) over a lifetime between intensive and conventional blood glucose treatment groups. METHODS:...

Bibliográfalaš dieđut
Váldodahkkit:	Lung, T, Clarke, P, Hayes, A, Stevens, R, Farmer, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

COST-EFFECTIVENESS OF RENAL SCREENING STRATEGIES AND TREATMENT OPTIONS FOR PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM
Dahkki: Lung, T, et al.
Almmustuhtton: (2012)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Dahkki: Clarke, P, et al.
Almmustuhtton: (2004)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
Dahkki: Hayes, A, et al.
Almmustuhtton: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
Dahkki: Hayes, A, et al.
Almmustuhtton: (2013)

Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach
Dahkki: Scott T. Chiesa, et al.
Almmustuhtton: (2021-06-01)

Monitoring Diabetes Mellitus Across the Lifetime of Illness
Dahkki: Farmer, A
Almmustuhtton: (2008)

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.
Dahkki: Oke, J, et al.
Almmustuhtton: (2013)

Monitoring young people with type 1 diabetes for diabetic nephropathy: Potential errors of annual ACR testing
Dahkki: Oke, J, et al.
Almmustuhtton: (2013)

An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
Dahkki: Hayes, A, et al.
Almmustuhtton: (2011)

Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia.
Dahkki: Hayes, A, et al.
Almmustuhtton: (2011)

Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
Dahkki: Yuanjie Mao, et al.
Almmustuhtton: (2025-01-01)

Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data
Dahkki: Hirst, J, et al.
Almmustuhtton: (2018)

Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India
Dahkki: Ashok Kumar Das, et al.
Almmustuhtton: (2012-01-01)

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.
Dahkki: Hayes, A, et al.
Almmustuhtton: (2011)

All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.
Dahkki: Taylor, K, et al.
Almmustuhtton: (2013)

Macronutrient intake and association with the risk factors of diabetic complications among people with type 2 diabetes
Dahkki: Meena Iqbal Farooqi, et al.
Almmustuhtton: (2021-04-01)

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
Dahkki: Tripolino C, et al.
Almmustuhtton: (2019-11-01)

Fish oil in people with type 2 diabetes mellitus.
Dahkki: Farmer, A, et al.
Almmustuhtton: (2001)

How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? A systematic Review
Dahkki: Hua, X, et al.
Almmustuhtton: (2016)

Disparities in the monitoring and complication screening of people with Type 2 diabetes
Dahkki: Hinton, W, et al.
Almmustuhtton: (2017)

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
Dahkki: Hirst, J, et al.
Almmustuhtton: (2013)

Health literacy and cardiovascular complications in people with type 2 Diabetes
Dahkki: Maria Vieira, et al.
Almmustuhtton: (2021-12-01)

Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes.
Dahkki: Farmer, A, et al.
Almmustuhtton: (2006)

Atrophy of the optic chiasm is associated with microvascular diabetic complications in type 1 diabetes
Dahkki: Aleksi Tarkkonen, et al.
Almmustuhtton: (2023-05-01)

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Dahkki: Becker, F, et al.
Almmustuhtton: (2018)

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996–2016
Dahkki: Bendix Carstensen, et al.
Almmustuhtton: (2021-03-01)

Educational Needs Associated with the Level of Complication and Comparative Risk Perceptions in People with Type 2 Diabetes
Dahkki: Youngji Hwang, et al.
Almmustuhtton: (2020-08-01)

Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
Dahkki: Jianchao Quan, et al.
Almmustuhtton: (2021-06-01)

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
Dahkki: Taylor, K, et al.
Almmustuhtton: (2012)

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
Dahkki: Hirst, J, et al.
Almmustuhtton: (2012)

Late onset type 1 diabetes.
Dahkki: Lasserson, D, et al.
Almmustuhtton: (2012)

Late onset type 1 diabetes
Dahkki: Lasserson, D, et al.
Almmustuhtton: (2012)

Late onset type 1 diabetes.
Dahkki: Lasserson, D, et al.
Almmustuhtton: (2012)

Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
Dahkki: Barbara H Braffett, et al.
Almmustuhtton: (2019-01-01)

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands
Dahkki: Moes RGJ, et al.
Almmustuhtton: (2023-02-01)

Factors associated with diabetes complications among people with type 2 diabetes in Sabah, Malaysia: A cross-sectional study
Dahkki: Alif Ramli, et al.
Almmustuhtton: (2024)

Association of cardiovascular health with diabetic complications, all-cause mortality, and life expectancy among people with type 2 diabetes
Dahkki: Yuan Zhang, et al.
Almmustuhtton: (2022-10-01)

Type 2 diabetes remission trajectories and variation in risk of diabetes complications: a population-based cohort study
Dahkki: Dampha-Miller, H, et al.
Almmustuhtton: (2023)

P5.18 CENTRAL HEMODYNAMIC’ S ARE ASSOCIATED WITH DIABETIC COMPLICATIONS IN TYPE 1 DIABETES
Dahkki: S. Theilade, et al.
Almmustuhtton: (2013-11-01)

The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
Dahkki: Anna Rydén, et al.
Almmustuhtton: (2016-01-01)